Showing results (11-20 of 94) with videos related to
Sort By:
Pageof 10
Annals of Translational Medicine|July 19, 2021
The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancerAbdul Rafeh Naqash, Alba J Kihn-Alarcón, Chara Stavraka, et al.Nature Reviews. Clinical Oncology|July 4, 2024
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancerTriparna Sen, Nobuyuki Takahashi, Subhamoy Chakraborty, et al.The Lancet. Oncology|November 28, 2023
Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trialsYu Fujiwara, Nobuyuki Horita, Elio Adib, et al.The Oncologist|February 8, 2024
Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical TrialsMuhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, et al.Journal for Immunotherapy of Cancer|January 10, 2019
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-seriesAbdul Rafeh Naqash, Danielle M File, Carolyn M Ziemer, et al.The Oncologist|August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer InstituteArjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.Nature Reviews. Clinical Oncology|February 18, 2026
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalizationDouglas B Johnson, Amin H Nassar, Ayesha Aijaz, et al.Cancer Letters|May 28, 2025
Anti-tumor effects on tumor-infiltrating natural killer cells by localized ablative immunotherapy and immune checkpoint inhibitors: An integrated and comparative study using scRNAseq analysisKaili Liu, Ashley R Hoover, Yuanhong Sun, et al.Cancer Cell|December 29, 2023
Benchmarking mismatch repair testing for patients with cancer receiving immunotherapyElias Bou Farhat, Elio Adib, Melissa Daou, et al.Journal for Immunotherapy of Cancer|July 7, 2019
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibitionAbdul Rafeh Naqash, Ebenezer Appah, Li V Yang, et al.Pageof 10